MAUREEN SCHULLER: Open Payments
NPI 1093018046 · LANCASTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,161 in 167 payments from 22 companies in 2025. Trend: 2023 $2,573 · 2024 $2,831 · 2025 $2,161
Food & beverage: $2,145Education: $16
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 57 | $420 |
| Novo Nordisk Inc | 19 | $343 |
| Madrigal Pharmaceuticals | 23 | $189 |
| Corcept Therapeutics | 13 | $162 |
| Lilly USA, LLC | 10 | $140 |
| Antares Pharma, Inc. | 7 | $132 |
| Amneal Pharmaceuticals LLC | 7 | $125 |
| CeQur Corporation | 1 | $96 |
| Abbott Laboratories | 4 | $76 |
| Xeris Pharmaceuticals, Inc. | 3 | $65 |
Products named: Dexcom G6 Transmitter, REZDIFFRA, Korlym, Ozempic, XYOSTED, UNITHROID, Wegovy, CeQur Simplicity.
Industry payments across PA — which companies pay providers there.
